Compassionate Use by Pranav Aurora

Subjects: “…Compassionate Use…”
Get full text

Conceptual clarifications regarding Chilean Act 20850 on public funding of high-cost diseases by Miguel Hugo Kottow Lang

Subjects: “…compassionate use…”

The economic impact of 14 compassionate use programs for medicines in Italy, in the perspective of the National Health Service by Claudio Jommi, Federico Pantellini, Giovanni Giuliani, Marianna Cavazza

Subjects: “…Compassionate use program…”
Get full text

Compassionate Use of Ripretinib for Patients With Metastatic Gastrointestinal Stromal Tumors: Taiwan and Hong Kong Experience by Li-Ching Lin, Wen-Kuan Huang, Chueh-Chuan Yen, Chueh-Chuan Yen, Ching-Yao Yang, Meng-Ta Sung, Natalie S. M. Wong, Daniel T. T. Chua, Sarah W. M. Lee, Jen-Shi Chen, Chun-Nan Yeh

Subjects: Get full text

Corrigendum: Compassionate use of ripretinib for patients with metastatic gastrointestinal stromal tumors: Taiwan and Hong Kong experience by Li-Ching Lin, Wen-Kuan Huang, Chueh-Chuan Yen, Chueh-Chuan Yen, Ching-Yao Yang, Meng-Ta Sung, Natalie S.M. Wong, Daniel T. T. Chua, Sarah W. M. Lee, Jen-Shi Chen, Chun-Nan Yeh

Subjects: Get full text

Current State of Compassionate Phage Therapy by Shawna McCallin, Jessica C. Sacher, Jan Zheng, Benjamin K. Chan

Subjects: Get full text

The economic impact of compassionate use of medicines by Claudio Jommi, Federico Pantellini, Lisa Stagi, Maria Verykiou, Marianna Cavazza

Subjects: “…Compassionate Use…”
Get full text

Compassionate Drug Use – Time Arising for a New Law in Bulgaria in the Era of COVID-19 by Nigyar Dzhafer, Jannis V. Papathanasiou

Subjects: Get full text

Opinion: Expanded Access for a Little Boy. by John Franklyn Riefler

Subjects: Get full text

The changing landscape of expanded access to investigational drugs for patients with unmet medical needs: ethical implications by Eline M. Bunnik, Nikkie Aarts, Suzanne van de Vathorst

Subjects: Get full text

Outcomes of pirtobrutinib for relapsed/refractory mantle cell lymphoma in compassionate use program in Europe by Enver Aydilek, Gerald Wulf, Friedrich Schwarz, Ulrike Bacher, Mathias Rummel, Olga Stiefel, Andrea Kerkhoff, Markus Maulhardt, Thomas Melchardt, Thomas Pabst, Georg Lenz, Evgenii Shumilov

Subjects: “…compassionate use program…”
Get full text

Off-label prescription of drugs at hospital by Vicente Arocas Casañ, Jaime Mateo Carmona, Olga García Molina, Mº Ángeles Fernández de Palencia Espinosa, Mª José Blázquez Álvarez Espinosa, Mª Amelia de la Rubia Nieto, Jesús del Río García

Subjects: Get full text

Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy by Victor Mocanu, Lindsay Mackay, Devon Christie, Elena Argento

Subjects: Get full text

Access to new medications for the treatment of drug-resistant tuberculosis: Patient, provider and community perspectives by Erica Lessem, Helen Cox, Colleen Daniels, Jennifer Furin, Lindsay McKenna, Carole D. Mitnick, Thato Mosidi, Caitlin Reed, Barbara Seaworth, Jonathan Stillo, Phumeza Tisile, Dalene von Delft

Subjects: Get full text

First clinical experience of isatuximab safety and tolerability in relapsed and refractory multiple myeloma: real-world data from a compassionate use program in Germany by Theo Leitner, Cyrus Khandanpour, Cyrus Khandanpour, Knut Wendelin, Fuat Oduncu, Christoph Kimmich, Ralph Naumann, Miriam Kull, Hartmut Goldschmidt, Martin Ehmer, Claudia Kiewitz, Hans Salwender

Subjects: Get full text

Five reasons why data on compassionate use of remdesivir deserved publication (and are worth reading) by Giuseppe Lapadula

Subjects: Get full text

Long-Term Survival and Immune Response Dynamics in Melanoma Patients Undergoing TAPCells-Based Vaccination Therapy by Andrés Tittarelli, Cristian Pereda, María A. Gleisner, Mercedes N. López, Iván Flores, Fabián Tempio, Alvaro Lladser, Adnane Achour, Fermín E. González, Claudia Durán-Aniotz, Juan P. Miranda, Milton Larrondo, Flavio Salazar-Onfray

Subjects: Get full text

Real‐world treatment outcomes of medicines used in special situations (off‐label and compassionate use) in oncology and hematology: A retrospective study from a comprehensive cance... by Sandra Fontanals, Anna Esteve, Andrea González, Cristina Ibáñez, Javier Martínez, Ricard Mesía, Ana Clopés

Subjects: Get full text

Efficacy and safety of compassionate use for rare diseases: a scoping review from 1991 to 2022 by Jiayu Wu, Yang Yang, Jiaxin Yu, Luyao Qiao, Wei Zuo, Bo Zhang

Subjects: “…Compassionate use…”
Get full text

First time compassionate use of laboratory engineered autologous Zurich skin in a massively burned child by Naiem Moiemen, Clemens Schiestl, Fabienne Hartmann-Fritsch, Kathrin Neuhaus, Ernst Reichmann, Arina Löw, Chantal Stenger, Sophie Böttcher-Haberzeth, Martin Meuli

Subjects: Get full text